drugset / Trial / NCT05283499
Opioid Analgesic Reduction Study (OARS) - Pilot
Phase 3
Completed
53 enrolled
Rutgers, The State University of New Jersey
University of Illinois at Chicago · collabUniversity of Maryland, Baltimore · collabUniversity of Michigan · collabUniversity of Rochester · collab
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
The purpose of this study is to test protocols being developed for the conduct of a large sale multi-site clinical trial which will compare opioids to non-opioids for managing post-surgical impacted 3rd molar extraction pain.
Timeline
- Start
- 2020-07-06
- Primary completion
- 2021-03-12
- Completion
- 2021-03-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrocodone | Unknown | 5 mg | — |
| Comparator | Ibuprofen | Small molecule | 400 mg | — |
| Comparator | Acetaminophen | Small molecule | 350 mg | — |
Indications
No indication recorded.